Cellular Biomedicine Group, Inc.
CBMG
CBMG was delisted on the 19th of February, 2021.
22 hedge funds and large institutions have $11.2M invested in Cellular Biomedicine Group, Inc. in 2015 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
2,600% more capital invested
Capital invested by funds: $416K → $11.2M (+$10.8M)
1,600% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 1
267% more funds holding
Funds holding: 6 → 22 (+16)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$2.54M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.31M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$823K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$575K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$452K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$152K |
CBMG Hedge Fund Activity: Q1 2015 in Review
22 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Cellular Biomedicine Group, Inc. (CBMG) for Q1 2015, worth a combined $11.2M — up 2,600% from $416K a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CBMG positions and 1 closed out — a net gain of 16 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was JP Morgan Private Wealth Advisors, opening a new position worth an estimated $2.54M. The largest seller was Goldman Sachs, exiting entirely with an estimated $152K sold.
- 22 institutional investors held Cellular Biomedicine Group, Inc. (CBMG) as of Q1 2015, up from 6 in Q4 2014.
- Funds reported $11.2M of Cellular Biomedicine Group, Inc. stock for Q1 2015, up 2,600% quarter-over-quarter.
- 17 funds opened new Cellular Biomedicine Group, Inc. positions in Q1 2015 and 1 closed out, a net change of +16 holders.
- The largest Cellular Biomedicine Group, Inc. buyer in Q1 2015 was JP Morgan Private Wealth Advisors, an estimated $2.54M added.
- The largest Cellular Biomedicine Group, Inc. seller in Q1 2015 was Goldman Sachs, an estimated $152K sold.
Based on aggregated 13F filings for Q1 2015.